Article
Targeting the mTOR Pathway Using Deforolimus in Cancer Therapy
17 Apr 2009
Abstract excerpt
The mammalian target of rapamycin (mTOR) is an intracellular protein with a key role in cellular protein synthesis and energy balance that influences many aspects of cell growth and proliferation, including differentiation, cell-cycle progression, angiogenesis, protein degradation and apoptosis. mTOR can be activated by numerous oncogenic signals, such as growth factor activation through the EGF, IGF and VEGF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
